Ondas’ nearly 40% short interest is fueling squeeze hopes as investors watch revenue growth and guidance.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

In the closing of the recent trading day, AeroVironment (AVAV) stood at $193.81, denoting a -1.13% move from the preceding trading day.

KTOS gains ground in unmanned systems and hypersonics, but supply-chain risks remain as investors weigh its growth and valuation.

Astronics (ATRO) delivered earnings and revenue surprises of +25.00% and +6.11%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Kopin is posting one of its sharpest single-session surges of the year after pairing a revenue beat with a partnership that could push its MicroLED technology into a market most investors never expected it to enter.
AeroVironment (AVAV) just landed the kind of contract that changes how investors see a company. The drone maker won a U.S. Army order worth at least $400 million for its Locust laser system, and the stock reacted fast. Shares closed at $186.73 on August 7, up 9.12% on the day and about 22% ...
Unusual Machines just posted revenue that obliterated Wall Street estimates, yet the EPS miss and a massive stock compensation charge tell a messier story beneath the headline. With the entire drone sector surging in lockstep, figuring out whether UMAC deserves its momentum or is simply riding a policy wave matters now.
Shares of Red Cat Holdings (NASDAQ:RCAT) are extending a sharp post-earnings rebound, rising 6.84% in Monday trading to $9.84. That builds on a 22.31% gain over the past week, a run that started from a $7.53 base on July 31. The question worth asking: is the entire drone group moving, or is this RCAT alone? ... Red Cat Holdings (RCAT) Stock Is Jumping Today: What’s Moving Drone Stocks?
AeroVironment recently announced a reported US$400 million U.S. Army production contract for its AI-assisted Locust directed-energy counter-drone system, alongside new board appointments and upcoming director retirements that reshape its governance profile. This combination of a landmark Pentagon directed-energy contract and added board-level aerospace-and-defense finance expertise could influence AeroVironment’s growth priorities and capital allocation decisions. We’ll now examine how the...
The reported contract would mark the Pentagon’s first production order for a directed-energy counter-drone system beyond the prototype stage.
↘️ Trade Desk (TTD): Shares in the advertising technology company fell 27% after it reported lower-than-expected quarterly revenue. ↗️ Atlassian (TEAM): Shares in the software company behind Jira and Confluence shot up 31% premarket following a revenue beat powered by accelerated growth in its cloud business.
AeroVironment (AVAV) closed at $171.12 in the latest trading session, marking a +1.82% move from the prior day.
ONDS stock surges 20.6% in a month as acquisitions and rising orders lift its outlook, but profitability issues and execution risks temper the upside case.
Fortinet and Ecopetrol have been highlighted as Zacks Bull and Bear of the Day
Iren peaked in Q3 2025 before sliding back, while AeroVironment's revenue more than tripled over the same period.
AMPX heads into Q2 results with revenues expected to surge 92.6% y/y, fueled by customer wins and rising SiCore battery adoption.
AeroVironment has gotten torched over the last six months - since January 2026, its stock price has dropped 45.5% to $147.13 per share. This might have investors contemplating their next move.
The push to end China's dominance in rare earth magnets is gaining momentum as North America builds an integrated supply chain from mine to magnet.
AeroVironment (AVAV) closed the most recent trading day at $156.35, moving +1.37% from the previous trading session.
Legal action and contract news put AeroVironment in focus Recent legal notices about a securities class action and a new US$117.3 million U.S. Army contract for P550 eVTOL drones have put AeroVironment (AVAV) in the spotlight for investors. See our latest analysis for AeroVironment. AeroVironment’s share price has recently moved higher, with a 1-day share price return of 3.16% and 30-day share price return of 11.81%. The stock is still down 39.79% year to date and the 1-year total shareholder...
AeroVironment stock has delivered a 61.9% gain over the past three years, yet its current valuation signals are split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while market based multiples lean the other way. That leaves investors weighing a mixed value score against both the recent share price pullback and a fresh contract win with the U.S. Army. The 61.9% return over three years suggests AeroVironment has rewarded patient holders, even though more...
Pentagon official warns about lagging U.S. drone production.
Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even bankruptcy.
AeroVironment (AVAV) closed at $150.35 in the latest trading session, marking a +1.01% move from the prior day.
Today, July 22, 2026, the drone and autonomous defense systems provider announced orders spanning ground systems, border security, and counter-UAS technologies.
Red Cat Holdings (NASDAQ:RCAT) stock is down 26% over the past month and down 8% today to $7.86, putting the drone maker at the heart of a broader shakeout in defense-tech names. The question is whether the group is out of fuel or simply cooling off after a large run higher. The answer looks mixed across ... Red Cat Just Dropped 26% in a Month: Are Drone Stocks Like RCAT, Ondas, Redwire, and AeroVironment Out of Fuel?
Investors will pay close attention to the effects of the new U.S. Army contract worth $117.30 million for AeroVironment stock.
AeroVironment secured a $117.3 million Army contract for P550 drones, yet shares are down over 40% year-to-date amid SCAR program uncertainty and analyst attention.
QUCY stock popped as news of the deal poured in, but the biotech-turned-defense contractor has a lot to prove.